ArticleBlood2014

The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm.

Veena Sangkhae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.